PubMed · 1996 · 61 citations · 30 references
Life SciencesCell BiologyPharmacologyApoptosisCell SignalingSignal TransductionAntibody CharacterizationApoptosis ModulationApoptosis RegulationApoptotic SignalingDeath ReceptorsTherapeutic Monoclonal AntibodiesAgonist ActivityApoptotic Neuronal DeathLigand Binding AffinityNerve Growth Factor SignalingPhosphatidylinositol 3-Kinase PathwayProtein Tyrosine PhosphorylationTrka SignalingTrkb Signaling
Monoclonal antibody (mAb) 5C3 directed against human p140 TrkA is a structural and functional mimic of nerve growth factor (NGF) and an artificial receptor agonist. mAb 5C3 binds in the NGF-docking site and, like NGF, it promotes TrkA internalization, TrkA and phosphatidylinositol-3 kinase tyrosine phosphorylation, and increased transformation of TrkA-expressing fibroblasts. More important, mAb 5C3 protects human TrkA-expressing cells from apoptotic death in serum-free media. Interestingly, agonistic activity is observed with monomeric F(ab) 5C3 fragments. mAb 5C3 (Kd approximately 2 nM) was used to study features of ligand binding by TrkA and the distribution of TrkA protein in normal human brain.
30
S M Hsu, Laurence Raine, Herbert Fanger · Journal of Histochemistry & Cytochemistry · 1981 · 14.3K citations · Full text
Antibodies, a laboratory manual
Biomedicine & Pharmacotherapy · 1989 · 12.5K citations
The trk proto-oncogene encodes a receptor for nerve growth factor
Rüdiger Klein, Venkata Nanduri, Edward C. O’Rourke et al. · Cell · 1991 · 1.4K citations